Vignette d'image

Peter, Olivier

Nom
Peter, Olivier
Affiliation principale
Identifiants
https://libra.unine.ch/handle/123456789/363

Résultat de la recherche

Filtres

2
2
Réinitialiser les filtres

Paramètres

Voici les éléments 1 - 2 sur 2
  • Publication
    Métadonnées seulement
    Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite
    (2004)
    Nahimana, I
    ;
    Gern, Lise 
    ;
    Blanc, D S
    ;
    Praz, G
    ;
    Francioli, P
    ;
    Peter, Olivier 
    The aim of this study was to define the risk of developing Lyme borreliosis after a tick bite. A survey was conducted from 1993 to 1995 in the western part of Switzerland in a group of patients who presented for treatment of a recent tick bite. Only patients with negative serological tests (enzyme-linked fluorescent assay screening test, and IgG and IgM immunoblots) at the first consultation and for whom a second blood sample was available 2 months later were included in the study. Of the 376 patients included, 266 had no clinical manifestation (group 1) and 110 had a small local cutaneous reaction (
  • Publication
    Métadonnées seulement
    Epidemiology of Lyme borreliosis in French-speaking Switzerland
    (2000)
    Nahimana, I
    ;
    Gern, Lise 
    ;
    Peter, Olivier 
    ;
    Praz, G
    ;
    Moosmann, Yves
    ;
    Francioli, P
    The purpose of this study was to assess the number of cases and the clinical aspects of Lyme borreliosis in French-speaking Switzerland. From July 1996 to December 1997, all laboratories performing serological tests for Lyme borreliosis sent a questionnaire to the treating physicians whenever the tests were positive. In addition, the physicians who diagnosed a case on clinical grounds only were also asked to report these cases. During this period, 1460 positive serological tests were recorded among approximately 10 360 performed (14%). A total of 775 questionnaires were returned (53%). In 3/4 of the cases, the test was ordered because of an acute clinical manifestation or a tick bite. The rest related to chronic symptoms or follow-up. In 504 cases (65%), diagnosis was considered certain or probable. These were erythema migrans in 46%, clinical manifestations of stage II in 33 % (26 facial palsy, 20 acute arthritis, 5 benign cutaneous lymphocytoma) and chronic symptoms in 21% (23 acrodermatitis, 26 neuropathies, and 8 arthritis). The adjusted incidence, estimated on the basis of the treating physician's place of residence, ranged from 9/100 000 in Valais to 95/100 000 in Neuchatel. This study indicates that Lyme borreliosis is a diagnosis frequently looked for and established in French-speaking Switzerland. Although erythema migrans is the main clinical manifestation, symptoms of stage II and III indicate that Lyme borreliosis is also responsible for relatively major systemic morbidity.